Skip to main content
Premium Trial:

Request an Annual Quote

Lexicon Posts Weak Q4 Revenue Growth, Widened Loss

NEW YORK, Feb. 20 - Lexicon Genetics today reported a slight dip in fourth-quarter revenue, increased R&D spending, and a jump in net losses.


Total revenue for the period ended Dec. 31 decreased to $10.1 million from $10.3 million one year ago. However, though receipts from subscription and license fees more than doubled to $6.2 million from $3.0 million, revenue growth was retarded due to Lexicon's decision last year no longer to sell its compound libraries but rather use them for internal research. That market brought in $3.4 million in revenue during the fourth quarter 2001. It generated just $5,000 in revenue during the current fourth quarter.


Fourth-quarter R&D spending grew to $19.2 million from $17.8 million year over year. As a result, net loss increased to $13.9 million, or $.26 per share, from $11 million, or $.21 per share, for the same period one year ago, the company said.


Lexicon said it had roughly $57.7 million in cash and investments as of Dec. 31.


Click here for more information.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.